monoclonal antibodies
Document de presse
2021.11.18
The team from the Cochin-Pasteur Clinical Investigation Center of Vaccinology at Cochin AP-HP Hospital, Inserm and the University of Paris, coordinated by Prof...
News
2021.11.10
As part of her trip to France for the fourth Paris Peace Forum – which includes three round tables on the challenges raised by the COVID-19 pandemic –, Kamala...
Document de presse
2021.09.27
The clinical manifestations of SARS-CoV-2 infection vary from one individual to the next, and much remains unknown about the mechanisms underpinning this...
Document de presse
2021.10.11
In a new study published in EMBO Journal on October 2, 2021, scientists from the Institut Pasteur, the CNRS, Université de Paris, the Vaccine Research...
Document de presse
2021.10.26
The SARS-CoV-2 virus, responsible for the COVID-19 pandemic, primarily targets the respiratory tract, but its ability to infect cells of the nervous system has...
Document de presse
2021.09.21
The teams from Henri-Mondor AP-HP hospital and Paris-Est Créteil University, Inserm, CNRS, University of Paris, within the Necker-Enfants Malades Institute,...
Document de presse
2021.08.19
Researchers and doctors from the AP-HP, the Institut Pasteur, the University of Paris and the Sorbonne University, have carried out work on the effect of...
Document de presse
2021.05.27
A study conducted by the University Hospital of Strasbourg (HUS) in collaboration with the Institut Pasteur, published as a preprint on medRxiv, has led to a...
Document de presse
2021.05.28
The Delta variant was detected for the first time in India in October 2020 and has since spread throughout the world. It is now dominant in many countries and...
Document de presse
2021.05.12
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed...